Onconetix, Inc.
ONCO • NASDAQ
Onconetix, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Karina Fedasz, with a market cap of $1.4M.
CEOKarina Fedasz
Next Earnings
Upcoming earnings announcement for Onconetix, Inc.
Date
Thursday, June 11, 2026 (in 2 months)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 11 earnings reports for Onconetix, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$6.25 | — | $303.7K | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$4.76 | — | $106.5K | — | 10-Q |
| Jun 12, 2025 | Q1 2025 | -$0.53 | — | $101.6K | — | 10-Q |
| Jun 2, 2025 | Q4 2024 | -$3.46 | — | $712.0K | — | 10-K |
| Dec 10, 2024 | Q3 2024 | -$2.93 | — | $406.9K | — | 10-Q |
| Aug 29, 2024 | Q2 2024 | -$25.60Est: $0.40 | -6500.0% | $704.8KEst: $15.0M | -95.3% | 10-Q |
| May 20, 2024 | Q1 2024 | -$20.00 | — | $700.4K | — | 10-Q |
| Apr 11, 2024 | Q4 2023 | -$52.00 | — | $58.5KEst: $58.0K | +0.8% | 10-K |
| Nov 17, 2023 | Q3 2023 | -$11.20Est: -$5.60 | -100.0% | - | — | — |
| Oct 20, 2023 | Q2 2023 | -$17.20Est: -$6.00 | -186.7% | - | — | 10-Q |
| May 12, 2023 | Q1 2023 | -$7.20 | — | - | — | — |